Degnan Chris 4
4 · Verrica Pharmaceuticals Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-02-28+44,000→ 44,000 totalExercise: $11.32Exp: 2029-02-27→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]25% of shares subject to the option shall vest on February 28, 2020 (the "Initial Vesting Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Initial Vesting Date, subject to the Reporting Person continuing to be a service provider through each such date.